Glenmark Pharma gets USFDA nod for erectile dysfunction treatment

Glenmark Pharmaceuticals Ltd has received final approval from the
United States Food and Drug Administration (USFDA) for Tadalafil
tablets USP in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, the
company said in a regulatory filing.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/glenmark-pharma-gets-usfda-nod-for-erectile-dysfunction-treatment/articleshow/80040795.cms

Comments

Popular posts from this blog

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

Biotecnika Times – Newsletter 25.01.2021 – CSIR Notice, CSIR-CCMB & ILS Hiring, FSSAI Funded